ACHIEVE LIFE SCIENCE INC

ACHV NASDAQ

kerdirks

We have a few more days before a breakout. Some nice upside potential as we are on the last leg up on the cypher pattern. As price action could change at any time, do your due diligence. Enjoy every sandwich ;) EES.

MillennialInvestmentsPros

ACHV has been trading within a Sideways Channel since Sept. 4th and is currently on the lower end of the channel. The stock has the potential to retest the $10 Levels of Resistance, and if it does, then we're expecting a $11.60-$13.48 wouldn't be impossible to see with this stock. ACHV began it's Late-Stage Trials of Cytisinicline for Smoking Cessation on 10/07/20...

amckee25

Low float name with a possible uptrend. Looking for a day with high volume (5M plus) for an opportunity. Scoop on dips with a tight leash or short on parabolic move.

CryptoFundManager

ACHIEVE LIFE SCIENCES ANNOUNCES START OF PHASE 3 ORCA-2 CLINICAL TRIAL EVALUATING CYTISINICLINE FOR SMOKING CESSATION COMPARED TO PLACEBO FOR 750 SMOKERS ACROSS 15 CLINICAL TRIAL SITES IN UNITED STATES. (Reuters) Results in 6 weeks. 22.349Market cap If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the...

Bullishcharts

ACHV potential trade setup on a break above $11.20 Upside target $12.55 & $13.90 Highly speculative so trade with care. Golden cross signal imminent

PennyStock101

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver,...

CryptoFundManager

INSTITUTIONAL OWNERSHIP in Achive LIfe Science grew 46 Million USD in the Q3 of 2020. Cytisinicline data will be featured in two presentations on Friday, September 18th, at the SRNT-E virtual conference. Both presentations evaluate positive findings from studies comparing cytisinicline to varenicline (Chantix®). If you are interested to test some amazing BUY...

CryptoFundManager

ACHV ACHIEVE LIFE SCIENCE INC NASDAQ trendline. If you are interested to test some amazing BUY and SELL INDICATORS, which give the signal at the beginning of the candle, not at the end of it, just leave me a message.

CryptoFundManager

On 8/7/2020 Brokerage LADENBURG THALM/SH SH Reiterated ACHV Rating to BUY and set the target price to $100.00, now the cost of one share is 9.84usd. You can find the asset on trading212, the most downloaded trading app in the U.K. With a market cap of $15.45 million and a worldwide working product, it`s hard to say ACHV can go lower than that. The only concern is...

Ayric

Wyckoff Schematic #2 seems to be in action. This has followed my plan so far, I just need it to pull back a bit more, or produce an entry signal for a Buy and Hold. Portfolio building is the key.

Barker

Better be long this one.

CryptoFundManager

On July 31th : Achieve Life Sciences receives U.S. patent for its novel analogs of cytisinicline for use in prevention or treatment of CNS and addictive disorders. Aimed at regaining compliance with Nasdaq's $1 minimum bid price listing requirement, Achieve Life Sciences has executed a 1:20 reverse split of its common stock. Achieve Life Sciences is scheduled...

DigitalData

This could break, bounce down inside and break up... or sometimes the high just cant be broken and but in on the low when i dips hard. Just have to see. Set alerts.

EcoTrader-tv

Hi, today we are going to talk about Achieve Life Sciences and its current landscape. Achieve Life Sciences has been surrounded by increasing speculation over its shares after a couple of days ago had unveiled an update on the cytisinicline (a drug to aid smoking cessation ) clinical development program, as the FDA had agreed with the overall Phase 3 study...

PennyStock101

********KEEP ON THE WATCHLIST FOR BREAKOUT, IMPROVED TRIAL RESULTS RELEASED, WITH CONFERENCE CALL TO FOLLOW LATER IN THE DAY******* Achieve Life Sciences, Inc. ACHV, clinical-stage pharmaceutical company focused on nicotine addiction, today announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the...

LionGate

In hindsight, the stock appears to be forming a downward trend all together aggregating moment to a strong bullish movement. Appear to be diligent as various announcements and press releases can also further regress the stock's overall valuation. Not investment advice, simply for personal and educational purposes only.

toanthainguyen

Buy signal detected. Both MACD and Momentum BUY signal detected

meitshel

nice round bottom strong EOW closing good news Achieve Life Sciences, Inc. Announces Closing of a $13.8 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option PR NewswireJune 19, 2018